Form 8-K - Current report:
SEC Accession No. 0001171843-24-006127
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:46
Documents
15
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_110724.htm   iXBRL 8-K 15268
2 PRESS RELEASE exh_991.htm EX-99.1 149641
  Complete submission text file 0001171843-24-006127.txt   378895

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_110724_htm.xml XML 3120
Mailing Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431
Business Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431 5616179100
Jushi Holdings Inc. (Filer) CIK: 0001909747 (see all company filings)

EIN.: 981547061 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56468 | Film No.: 241435534
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)